第一个国际经验与组织缩:对230个病例的安全性分析
Chase J Wehrle1, Kevin Burns2, Evan Ong3
1Division of Hepatopancreatobiliary Surgery and Liver Transplantation, Cleveland Clinic, Cleveland, OH, United States.
概括
基斯托里普西是一种新的超声波肝脏瘤治疗方法,在现实世界中使用时显示出有前途的安全性. 发生的并发症很少,严重事件与晚期疾病有关,而不是手术本身.
科学领域:
- 在瘤学瘤学.
- 医疗技术 医疗技术 医学技术
- 肝病学 肝病学是一种肝病学.
背景情况:
- 组织透是一种创新的,非侵入性的,非热的,非电离的聚焦超声波技术,用于肝脏瘤治疗.
- 美国食品和药物管理局在2023年底授予了对基因的de novo清除.
- 这项研究介绍了FDA批准后的初始真实世界的临床安全数据.
研究的目的:
- 报告第一个试验后的,真实世界的肝脏瘤组织缩的临床安全结果.
- 评估在多样化的患者群体和瘤类型中组织缩的安全概况.
- 为了比较基因组的安全性与现有的肝疗法和手术疗法.
主要方法:
- 安全结果是在2023年12月至2024年7月的前列腺抽血后30天内收集的.
- 从所有参与的中心收集了数据,这些中心进行了基因组缩.
- 用克拉维恩 - 丁多分类和综合性并发症指数 (CCI) 来分类并发症.
主要成果:
- 在18个中心治疗了295名510名肝脏瘤 (包括转移,HCC和神经内分泌瘤) 的患者.
- 来自230名患者的安全数据显示,并发症率为5.2%,其中大多数是轻微的 (Clavien-Dindo等级≤II).
- 三个主要并发症 (1.3%) 是患有息治疗的患者因疾病进展而死亡.
结论:
- 在现实世界的临床实践中,体瘤在治疗肝脏瘤方面表现出有利的安全性.
- 该技术耐受性很好,整体和严重并发症的发生率很低.
- 基因组的安全性与其他肝脏瘤疗法相比较有利,这需要进一步进行瘤结局研究.
更多相关视频
05:56Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
Published on: January 9, 2019
7.7K
07:50An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
2.6K
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
01:23Investigation of Disease Outbreaks
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...